Ghazaleh Sadri-Vakili, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 10 | 2024 | 1414 | 2.910 |
Why?
|
| Huntington Disease | 18 | 2023 | 1124 | 2.450 |
Why?
|
| Cocaine | 11 | 2017 | 1007 | 2.170 |
Why?
|
| Brain-Derived Neurotrophic Factor | 11 | 2017 | 604 | 1.850 |
Why?
|
| Histones | 15 | 2020 | 2598 | 1.710 |
Why?
|
| Motor Cortex | 3 | 2021 | 986 | 1.300 |
Why?
|
| Cocaine-Related Disorders | 8 | 2014 | 460 | 1.150 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2020 | 372 | 1.130 |
Why?
|
| Dystonic Disorders | 2 | 2020 | 329 | 1.110 |
Why?
|
| Dopamine Uptake Inhibitors | 4 | 2014 | 312 | 0.970 |
Why?
|
| Spinal Cord | 4 | 2020 | 1810 | 0.960 |
Why?
|
| Prefrontal Cortex | 6 | 2023 | 2147 | 0.890 |
Why?
|
| Corpus Striatum | 7 | 2015 | 1221 | 0.850 |
Why?
|
| Histone Deacetylase Inhibitors | 5 | 2019 | 789 | 0.830 |
Why?
|
| Motor Neurons | 4 | 2024 | 844 | 0.790 |
Why?
|
| Transcription Factor TFIID | 1 | 2020 | 151 | 0.730 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2020 | 104 | 0.720 |
Why?
|
| Histone Deacetylases | 4 | 2019 | 728 | 0.700 |
Why?
|
| Cromolyn Sodium | 1 | 2019 | 87 | 0.690 |
Why?
|
| Nerve Tissue Proteins | 11 | 2015 | 4463 | 0.670 |
Why?
|
| Soybean Proteins | 1 | 2019 | 61 | 0.660 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 335 | 0.660 |
Why?
|
| Acetylation | 8 | 2020 | 1084 | 0.620 |
Why?
|
| Receptor, trkB | 3 | 2017 | 125 | 0.610 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 3646 | 0.570 |
Why?
|
| tau Proteins | 3 | 2024 | 1868 | 0.540 |
Why?
|
| Astrocytes | 3 | 2020 | 1273 | 0.530 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 12073 | 0.530 |
Why?
|
| Neuroprotective Agents | 2 | 2019 | 941 | 0.530 |
Why?
|
| Receptors, AMPA | 3 | 2014 | 332 | 0.520 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 1061 | 0.500 |
Why?
|
| Drug-Seeking Behavior | 1 | 2014 | 48 | 0.490 |
Why?
|
| Nuclear Proteins | 10 | 2019 | 5856 | 0.460 |
Why?
|
| Genes, Immediate-Early | 1 | 2013 | 101 | 0.460 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 574 | 0.460 |
Why?
|
| Neural Stem Cells | 2 | 2018 | 851 | 0.450 |
Why?
|
| Oxidative Stress | 2 | 2021 | 3084 | 0.440 |
Why?
|
| Adenosine Deaminase | 1 | 2014 | 241 | 0.430 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 191 | 0.410 |
Why?
|
| CREB-Binding Protein | 1 | 2011 | 151 | 0.400 |
Why?
|
| Dendrites | 1 | 2014 | 485 | 0.400 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 340 | 0.390 |
Why?
|
| Disease Models, Animal | 16 | 2023 | 18034 | 0.390 |
Why?
|
| Phosphorylation | 7 | 2023 | 8436 | 0.390 |
Why?
|
| Down-Regulation | 5 | 2013 | 3001 | 0.380 |
Why?
|
| Intranuclear Inclusion Bodies | 2 | 2010 | 37 | 0.380 |
Why?
|
| Dopamine | 3 | 2008 | 1591 | 0.380 |
Why?
|
| Epigenomics | 2 | 2013 | 903 | 0.370 |
Why?
|
| Ventral Tegmental Area | 1 | 2011 | 142 | 0.370 |
Why?
|
| Inflammation | 2 | 2020 | 10637 | 0.370 |
Why?
|
| Behavior, Addictive | 2 | 2013 | 462 | 0.370 |
Why?
|
| Synapses | 2 | 2021 | 1728 | 0.360 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1790 | 0.350 |
Why?
|
| Brain | 10 | 2019 | 26388 | 0.340 |
Why?
|
| Self Administration | 5 | 2014 | 385 | 0.340 |
Why?
|
| Mice, Transgenic | 13 | 2023 | 9735 | 0.340 |
Why?
|
| Pregnenolone | 1 | 2008 | 26 | 0.340 |
Why?
|
| Mitochondria | 1 | 2021 | 3514 | 0.320 |
Why?
|
| Signal Transduction | 6 | 2018 | 23404 | 0.320 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2017 | 2408 | 0.310 |
Why?
|
| Benzodiazepines | 1 | 2013 | 1101 | 0.310 |
Why?
|
| Conditioning, Operant | 3 | 2014 | 313 | 0.300 |
Why?
|
| Animals | 39 | 2023 | 168768 | 0.300 |
Why?
|
| RNA, Messenger | 8 | 2019 | 13035 | 0.300 |
Why?
|
| N-Methylaspartate | 2 | 2008 | 231 | 0.300 |
Why?
|
| Neurons | 6 | 2021 | 9340 | 0.290 |
Why?
|
| Transcription, Genetic | 9 | 2018 | 7721 | 0.280 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 634 | 0.270 |
Why?
|
| Rats | 12 | 2016 | 24252 | 0.260 |
Why?
|
| Anesthetics, Local | 1 | 2011 | 985 | 0.250 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 1148 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 3873 | 0.240 |
Why?
|
| Nucleus Accumbens | 3 | 2014 | 366 | 0.240 |
Why?
|
| Succinates | 1 | 2003 | 82 | 0.230 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 5709 | 0.220 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2013 | 894 | 0.220 |
Why?
|
| Mice | 22 | 2023 | 81201 | 0.220 |
Why?
|
| Pregnanolone | 1 | 2003 | 62 | 0.220 |
Why?
|
| Prosencephalon | 2 | 2017 | 303 | 0.210 |
Why?
|
| Microglia | 2 | 2020 | 1267 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2014 | 8300 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 4751 | 0.200 |
Why?
|
| Hippocampus | 1 | 2013 | 3675 | 0.190 |
Why?
|
| Gene Fusion | 1 | 2024 | 371 | 0.190 |
Why?
|
| Blotting, Western | 3 | 2020 | 5181 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 6 | 2013 | 5867 | 0.190 |
Why?
|
| Ornithine | 1 | 2020 | 78 | 0.190 |
Why?
|
| Serine | 2 | 2023 | 826 | 0.180 |
Why?
|
| Tauopathies | 1 | 2024 | 307 | 0.180 |
Why?
|
| Fibroblasts | 2 | 2020 | 4162 | 0.180 |
Why?
|
| Leukocyte Elastase | 1 | 2020 | 113 | 0.180 |
Why?
|
| Retroelements | 1 | 2020 | 164 | 0.170 |
Why?
|
| Gliosis | 1 | 2020 | 245 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 21833 | 0.170 |
Why?
|
| Male | 26 | 2021 | 350115 | 0.160 |
Why?
|
| Phosphoproteins | 2 | 2018 | 2441 | 0.160 |
Why?
|
| Adamantane | 1 | 2019 | 173 | 0.160 |
Why?
|
| Steroids | 1 | 2003 | 930 | 0.160 |
Why?
|
| Carbon Radioisotopes | 1 | 2019 | 577 | 0.160 |
Why?
|
| Introns | 1 | 2020 | 992 | 0.160 |
Why?
|
| Methylation | 4 | 2014 | 1106 | 0.150 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 214 | 0.150 |
Why?
|
| Substance-Related Disorders | 2 | 2014 | 4257 | 0.150 |
Why?
|
| Neuromuscular Junction | 1 | 2019 | 397 | 0.150 |
Why?
|
| Peroxidase | 1 | 2020 | 611 | 0.150 |
Why?
|
| Humans | 30 | 2024 | 744366 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2917 | 0.140 |
Why?
|
| Autopsy | 1 | 2020 | 1020 | 0.140 |
Why?
|
| RNA Editing | 2 | 2014 | 148 | 0.140 |
Why?
|
| Reversal Learning | 1 | 2016 | 60 | 0.140 |
Why?
|
| Cell Death | 2 | 2020 | 1707 | 0.140 |
Why?
|
| Hydroxamic Acids | 1 | 2019 | 494 | 0.140 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2016 | 124 | 0.140 |
Why?
|
| Chemokines | 1 | 2020 | 970 | 0.140 |
Why?
|
| Ubiquitination | 2 | 2013 | 1012 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 2505 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2019 | 2214 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3799 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2019 | 4554 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57776 | 0.130 |
Why?
|
| Phosphatidic Acids | 1 | 2015 | 49 | 0.130 |
Why?
|
| Glycerophospholipids | 1 | 2015 | 32 | 0.130 |
Why?
|
| Cytokines | 2 | 2020 | 7323 | 0.130 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2016 | 302 | 0.120 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2014 | 170 | 0.120 |
Why?
|
| Reinforcement Schedule | 2 | 2011 | 129 | 0.120 |
Why?
|
| Triazolam | 1 | 2013 | 16 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 16690 | 0.120 |
Why?
|
| Cell Separation | 1 | 2020 | 1751 | 0.120 |
Why?
|
| Phenotype | 5 | 2016 | 16367 | 0.120 |
Why?
|
| Disease Progression | 2 | 2021 | 13286 | 0.110 |
Why?
|
| Female | 15 | 2021 | 380193 | 0.110 |
Why?
|
| Diazepam | 1 | 2013 | 205 | 0.110 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 270 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2019 | 2618 | 0.110 |
Why?
|
| Liver Regeneration | 1 | 2014 | 210 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2016 | 1341 | 0.110 |
Why?
|
| Uric Acid | 1 | 2018 | 766 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 2015 | 331 | 0.110 |
Why?
|
| Cells, Cultured | 6 | 2020 | 19233 | 0.110 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 4253 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2019 | 828 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21748 | 0.100 |
Why?
|
| Histone Deacetylase 1 | 1 | 2012 | 137 | 0.100 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 913 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 514 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 575 | 0.100 |
Why?
|
| Ubiquitins | 1 | 2013 | 384 | 0.100 |
Why?
|
| Aged | 5 | 2021 | 163288 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2017 | 2455 | 0.090 |
Why?
|
| Antioxidants | 1 | 2018 | 1659 | 0.090 |
Why?
|
| Cell Survival | 1 | 2020 | 5882 | 0.090 |
Why?
|
| Frontal Lobe | 1 | 2016 | 1406 | 0.090 |
Why?
|
| DNA Methylation | 2 | 2015 | 4285 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 627 | 0.090 |
Why?
|
| Middle Aged | 6 | 2021 | 213390 | 0.090 |
Why?
|
| Sp1 Transcription Factor | 2 | 2008 | 144 | 0.080 |
Why?
|
| Protein Binding | 3 | 2018 | 9384 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 1157 | 0.080 |
Why?
|
| Receptors, sigma | 1 | 2008 | 28 | 0.080 |
Why?
|
| Lysine | 1 | 2013 | 1007 | 0.080 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2006 | 186 | 0.080 |
Why?
|
| Peptides | 2 | 2012 | 4410 | 0.080 |
Why?
|
| Self Report | 1 | 2019 | 3553 | 0.080 |
Why?
|
| Aging | 2 | 2017 | 8664 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 173 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6366 | 0.070 |
Why?
|
| Memory | 1 | 2016 | 2174 | 0.070 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2011 | 632 | 0.070 |
Why?
|
| Enkephalins | 1 | 2006 | 154 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2887 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 596 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2019 | 6194 | 0.060 |
Why?
|
| RNA | 1 | 2014 | 2749 | 0.060 |
Why?
|
| Transcription Factors | 4 | 2018 | 12207 | 0.060 |
Why?
|
| Somatostatin | 1 | 2006 | 459 | 0.060 |
Why?
|
| Environment | 1 | 2010 | 1123 | 0.060 |
Why?
|
| Genome | 1 | 2012 | 1807 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1525 | 0.060 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2006 | 475 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2014 | 2974 | 0.060 |
Why?
|
| Cell Line | 2 | 2018 | 16000 | 0.060 |
Why?
|
| Microdialysis | 1 | 2003 | 158 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 6234 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2006 | 1783 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2003 | 146 | 0.060 |
Why?
|
| Time Factors | 3 | 2014 | 40075 | 0.060 |
Why?
|
| Cholesterol | 1 | 2012 | 2919 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7914 | 0.050 |
Why?
|
| Research Design | 1 | 2019 | 5984 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 425 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2012 | 2575 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 8038 | 0.050 |
Why?
|
| Gene Expression | 2 | 2013 | 7798 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10943 | 0.050 |
Why?
|
| Cell Movement | 2 | 2012 | 5218 | 0.050 |
Why?
|
| Microinjections | 1 | 2003 | 327 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2008 | 1169 | 0.050 |
Why?
|
| Mice, Inbred CBA | 2 | 2013 | 448 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 1950 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2006 | 982 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2015 | 418 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2006 | 1154 | 0.050 |
Why?
|
| Pyridines | 1 | 2013 | 2825 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 1178 | 0.050 |
Why?
|
| Adult | 3 | 2020 | 214052 | 0.050 |
Why?
|
| Calcium | 1 | 2014 | 5755 | 0.050 |
Why?
|
| Chromatin | 1 | 2013 | 2933 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2010 | 4222 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15520 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8432 | 0.050 |
Why?
|
| Pregnancy | 3 | 2017 | 29144 | 0.040 |
Why?
|
| Behavior, Animal | 2 | 2008 | 1881 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 9647 | 0.040 |
Why?
|
| Models, Animal | 2 | 2016 | 2173 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7475 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10483 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25039 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2016 | 2969 | 0.040 |
Why?
|
| Food Preferences | 2 | 2012 | 399 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2013 | 12262 | 0.040 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2016 | 37 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2018 | 537 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3751 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 96 | 0.030 |
Why?
|
| Cyclin E | 1 | 2016 | 172 | 0.030 |
Why?
|
| Corticosterone | 1 | 2016 | 310 | 0.030 |
Why?
|
| Synaptosomes | 1 | 2015 | 115 | 0.030 |
Why?
|
| DNA | 1 | 2008 | 7294 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 644 | 0.030 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2015 | 170 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 2014 | 232 | 0.030 |
Why?
|
| Conditioning, Classical | 1 | 2016 | 366 | 0.030 |
Why?
|
| Drosophila melanogaster | 2 | 2013 | 1708 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2015 | 191 | 0.030 |
Why?
|
| Grooming | 1 | 2012 | 37 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2016 | 553 | 0.030 |
Why?
|
| Motor Activity | 1 | 2003 | 2715 | 0.030 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2013 | 115 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3921 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2014 | 1162 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11366 | 0.030 |
Why?
|
| Protein Transport | 2 | 2008 | 1988 | 0.030 |
Why?
|
| Mutation | 3 | 2018 | 29786 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2016 | 703 | 0.030 |
Why?
|
| Sucrose | 1 | 2012 | 164 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2016 | 749 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 35425 | 0.030 |
Why?
|
| Caffeine | 1 | 2016 | 699 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2012 | 409 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 453 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2014 | 550 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 2011 | 245 | 0.020 |
Why?
|
| Azepines | 1 | 2012 | 334 | 0.020 |
Why?
|
| Histone Demethylases | 1 | 2013 | 321 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2010 | 178 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2010 | 374 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2012 | 296 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2016 | 1211 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2012 | 655 | 0.020 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2008 | 58 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 2251 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2010 | 243 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2011 | 471 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2949 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 1865 | 0.020 |
Why?
|
| Quebec | 1 | 2008 | 134 | 0.020 |
Why?
|
| Scotland | 1 | 2008 | 155 | 0.020 |
Why?
|
| Ireland | 1 | 2008 | 161 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 712 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1549 | 0.020 |
Why?
|
| Binding Sites | 2 | 2008 | 6111 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3702 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1423 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 3464 | 0.020 |
Why?
|
| Diltiazem | 1 | 2008 | 133 | 0.020 |
Why?
|
| Cerebellum | 1 | 2015 | 1488 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2204 | 0.020 |
Why?
|
| Threonine | 1 | 2008 | 279 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2726 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 898 | 0.020 |
Why?
|
| Benzamides | 1 | 2012 | 1379 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2008 | 240 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2008 | 291 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 449 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1539 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 9445 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 1701 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 1121 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2008 | 355 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 913 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2011 | 838 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 692 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 1295 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 2890 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2076 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 18373 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1787 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2012 | 2585 | 0.010 |
Why?
|
| Age of Onset | 1 | 2008 | 3270 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2219 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2012 | 3188 | 0.010 |
Why?
|
| Child | 2 | 2019 | 77709 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 85779 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4185 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 4328 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 12797 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2008 | 3024 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11486 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 35134 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 12952 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17446 | 0.000 |
Why?
|
| Risk Factors | 1 | 2008 | 72296 | 0.000 |
Why?
|
| United States | 1 | 2008 | 69872 | 0.000 |
Why?
|